Fuentespina, Cecil C.
HRN: 21-50-12 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
CEFUROXIME 1.5GM (VIAL)
06/17/2022
06/17/2022
IVT
1.5g
On Call To OR
For LTCS, Surgical Prophylaxis
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes